Alessio Pigazzi, MD
Colon & Rectal Surgery · Los Angeles, CANPI 1205935913
Payments from drug & device makers
What this record shows
The money is spread across several categories — speaking fees (45.0%), consulting fees and education — rather than concentrated in one kind of arrangement. 10 manufacturers reported payments, led by Covidien LP at 35.8% of the total. Reporting peaked in 2019 at $50,527 and has fallen 98.0% since, to $1,008 in 2025. Among colon & rectal surgery clinicians in CA with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 96 payments — averaging $1036.72 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Covidien LP$36K
- Johnson & Johnson$24K
- Intuitive Surgical$22K
- Medtronic$17K
- Bard Peripheral Vascular, Inc.$181
- Integra Lifesciences Corporation$175
- plus $434 from 4 others
Across 4 payments — averaging $570.55 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Medtronic$2K
What the payments were for
- Consulting fees$23,53524%
- Speaking & faculty fees$44,75045%
- Travel & lodging$9,3269%
- Food & beverage$2,7843%
- Education$19,13019%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Covidien LP | 24 | $35,670 |
| Johnson & Johnson | 21 | $23,526 |
| Intuitive Surgical | 24 | $22,111 |
| Medtronic | 20 | $17,427 |
| Bard Peripheral Vascular, Inc. | 1 | $181 |
| Integra Lifesciences Corporation | 1 | $175 |
| Coloplast | 2 | $130 |
| Acelrx Pharmaceuticals, Inc. | 1 | $123 |
| Axonics, Inc. | 1 | $98 |
| Vioptix Inc | 1 | $83 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Da Vinci Surgical System$21,844
- Monarch Platform$7,460
- Sonicision$7,000
- STRATAFIX$1,065
- INTEGRA$350
- Lutonix Drug Coated Balloon$181
- OMNIGRAFT$175
- SURGIMEND$175
- INTEGRA DERMAL REGENERATION TEMPLATE$175
- DSUVIA$123
- Signia$123
- RESTORELLE$100
How this compares
$99,526 in reported general payments places this provider in the 95th percentile of 176 colon & rectal surgery providers in California.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other colon & rectal surgery in Los Angeles
- Sang LeeLos Angeles$2.4M
- Kevork KazanjianLos Angeles$37K
- Joongho ShinLos Angeles$25K
- Clifford KoLos Angeles$24K
- Sarah KollerLos Angeles$16K
- Anne LinLos Angeles$14K
- Christine HsiehLos Angeles$11K
- Marjun DuldulaoLos Angeles$11K
- Glenn AultLos Angeles$11K
- Kyle CologneLos Angeles$10K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.